His scientific interests lie mostly in Psychiatry, Anxiety disorder, Anxiety, Internal medicine and Placebo. He has included themes like Randomized controlled trial and Clinical psychology in his Psychiatry study. The Anxiety disorder study combines topics in areas such as Avoidant personality disorder, Nosology, Cognitive therapy and Comorbidity.
In general Anxiety, his work in Panic, Panic disorder and Shyness is often linked to Discriminant validity linking many areas of study. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Endocrinology, Phobic disorder and Sertraline. His studies deal with areas such as Adverse effect, Pharmacotherapy, Chemotherapy and Phenelzine as well as Placebo.
Psychiatry, Anxiety, Anxiety disorder, Internal medicine and Panic are his primary areas of study. Psychiatry and Clinical psychology are commonly linked in his work. In the subject of general Anxiety, his work in Shyness is often linked to Discriminant validity, thereby combining diverse domains of study.
He interconnects Nosology, Developmental psychology, Generalized anxiety disorder, Cognitive therapy and Reuptake inhibitor in the investigation of issues within Anxiety disorder. His Internal medicine research incorporates elements of Placebo and Endocrinology. His study in Panic is interdisciplinary in nature, drawing from both Anesthesia and Panic disorder.
Michael R. Liebowitz mainly investigates Psychiatry, Social anxiety, Anxiety, Placebo and Clinical psychology. His Psychiatry research is multidisciplinary, incorporating perspectives in Randomized controlled trial and Placebo-controlled study. His Social anxiety study combines topics in areas such as Psychopharmacology, Phobic disorder, Psychometrics and Paroxetine.
Clinical trial is closely connected to Depression in his research, which is encompassed under the umbrella topic of Anxiety. Michael R. Liebowitz combines subjects such as Anesthesia, Internal medicine, Tolerability and Anxiolytic with his study of Placebo. His Clinical psychology research focuses on subjects like Comorbidity, which are linked to Psychopathology.
Michael R. Liebowitz mostly deals with Anxiety disorder, Psychiatry, Social anxiety, Placebo and Internal medicine. His study looks at the intersection of Anxiety disorder and topics like Pharmacotherapy with Cognitive therapy and Clomipramine. His Psychiatry study frequently draws connections to other fields, such as Sex characteristics.
Social anxiety is a subfield of Anxiety that Michael R. Liebowitz investigates. As a part of the same scientific study, he usually deals with the Anxiety, concentrating on Confirmatory factor analysis and frequently concerns with Clinical psychology. His Internal medicine research includes elements of Nasal spray and Phobic disorder.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Social Phobia: Comorbidity and Morbidity in an Epidemiologic Sample
Franklin R. Schneier;Jim Johnson;Christopher D. Hornig;Michael R. Liebowitz.
Archives of General Psychiatry (1992)
Psychometric properties of the Liebowitz Social Anxiety Scale.
Richard G. Heimberg;K. J. Horner;H. R. Juster;S. A. Safren.
Psychological Medicine (1999)
The Liebowitz Social Anxiety Scale: a comparison of the psychometric properties of self-report and clinician-administered formats
D. M. Fresco;M. E. Coles;R. G. Heimberg;M. R. Liebowitz.
Psychological Medicine (2001)
Assessment of anxiety in social interaction and being observed by others: The social interaction anxiety scale and the Social Phobia Scale
Richard G. Heimberg;Gregory P. Mueller;Craig S. Holt;Debra A. Hope.
Behavior Therapy (1992)
Social phobia. Review of a neglected anxiety disorder
Michael R. Liebowitz;Jack M. Gorman;Abby J. Fyer;Donald F. Klein.
Archives of General Psychiatry (1985)
Cognitive Behavioral Group Therapy vs Phenelzine Therapy for Social Phobia: 12-Week Outcome
Richard G. Heimberg;Michael R. Liebowitz;Debra A. Hope;Franklin R. Schneier.
Archives of General Psychiatry (1998)
Functional impairment in social phobia.
Franklin R. Schneier;Leora R. Heckelman;Robin Garfinkel;Raphael Campeas.
The Journal of Clinical Psychiatry (1994)
Phenelzine vs atenolol in social phobia: A placebo-controlled comparison.
Michael R. Liebowitz;Frank Schneier;Raphael Campeas;Eric Hollander.
Archives of General Psychiatry (1992)
Empirical validation and psychometric evaluation of the Brief Fear of Negative Evaluation Scale in patients with social anxiety disorder.
Justin W. Weeks;Richard G. Heimberg;David M. Fresco;Trevor A. Hart.
Psychological Assessment (2005)
Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial
Stein Mb;Liebowitz Mr;Lydiard Rb;Pitts Cd.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: